Top Page
INNOVATE Corp
(NYSE:VATE)
INNOVATE Corp (VATE) vs. SPDR S&P 500 ETF (SPY)
INNOVATE Corp Business Overview & Revenue Model
INNOVATE Corp Earnings Call Summary
INNOVATE Corp Financial Statement Overview
| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 995.00M | 1.11B | 1.42B | 1.64B | 1.21B | 1.01B |
| Gross Profit | 185.70M | 208.80M | 216.00M | 221.40M | 183.70M | 167.30M |
| EBITDA | -4.80M | -99.00M | 69.80M | 53.10M | 16.00M | 54.90M |
| Net Income | -78.10M | -35.80M | -37.60M | -40.80M | -79.80M | -46.40M |
Balance Sheet | ||||||
| Total Assets | 890.90M | 891.10M | 1.04B | 1.15B | 1.08B | 6.74B |
| Cash, Cash Equivalents and Short-Term Investments | 33.40M | 48.80M | 80.80M | 80.40M | 45.50M | 4.69B |
| Total Debt | 477.50M | 719.20M | 771.90M | 714.40M | 626.30M | 561.50M |
| Total Liabilities | 1.08B | 1.03B | 1.18B | 1.18B | 1.07B | 6.14B |
| Stockholders Equity | 17.10M | -180.40M | -149.10M | -103.70M | -65.50M | 559.80M |
Cash Flow | ||||||
| Free Cash Flow | 2.10M | -9.90M | 8.10M | -30.20M | 2.90M | 23.90M |
| Operating Cash Flow | 23.10M | 9.10M | 26.50M | -9.50M | 27.00M | 41.70M |
| Investing Cash Flow | 71.80M | -13.90M | 39.10M | -22.50M | -223.20M | 162.30M |
| Financing Cash Flow | -162.80M | -26.50M | -65.30M | 68.10M | 4.30M | -204.60M |
INNOVATE Corp Technical Analysis
INNOVATE Corp Risk Analysis
INNOVATE Corp Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | $167.68M | 9.10 | 41.26% | 0.59% | 4.62% | 81.73% | |
73 Outperform | $3.72B | 24.54 | 32.91% | ― | 11.92% | 8.94% | |
71 Outperform | ¥258.06B | 14.45 | 8.48% | 2.82% | 6.32% | 12.21% | |
65 Neutral | $293.64M | 25.27 | 7.90% | ― | 15.85% | ― | |
46 Neutral | $76.51M | ― | 17.11% | ― | -24.94% | 51.41% | |
44 Neutral | $61.20M | ― | -679.42% | ― | -18.08% | -217.13% | |
44 Neutral | $229.48M | ― | -53.62% | ― | -20.63% | -611.23% |
INNOVATE Corp Corporate Events
INNOVATE Corp announced its second quarter 2025 results, highlighting a decrease in consolidated revenue by 22.7% compared to the previous year, primarily due to declines in the Infrastructure and Spectrum segments. Despite the revenue drop, the company emphasized its strategic refinancing transactions that extend debt maturities, and noted growth in its Life Sciences segment, particularly with the FDA-approved MediBeacon system and R2’s increased sales. The company is also exploring new datacasting opportunities in its Spectrum segment, aiming for improved performance in the latter half of the year.
On August 4, 2025, INNOVATE Corp completed a series of refinancing transactions to extend the maturities of 81.7% of its outstanding debt as of June 30, 2025. This strategic move includes the exchange of senior secured notes, convertible notes, and amendments to various credit agreements, which is expected to enhance the company’s financial flexibility and potentially improve its market positioning.
INNOVATE Corp. announced early results of its exchange offer for its 8.5% Senior Secured Notes due 2026, with a successful tender of 99.41% of the notes, meeting the minimum exchange condition. The company will extend eligibility for the Total Early Exchange Consideration until the expiration deadline, with early settlement expected on August 4, 2025, and final settlement on August 15, 2025. This move aims to enhance the company’s financial structure by exchanging notes for newly issued 10.5% Senior Secured Notes due 2027, which include updated covenants and an increased interest rate.
On July 28, 2025, INNOVATE Corp. announced that its subsidiary, DBM Global Inc., will distribute a cash dividend of approximately $4.4 million, or $1.14 per share, to its stockholders on August 21, 2025. As the largest stockholder, INNOVATE expects to receive around $4 million of this payout, highlighting its significant stake in DBM Global and the financial benefits accruing from this investment.
On July 17, 2025, INNOVATE Corp. announced plans to refinance its debt through a series of transactions, including exchanging convertible senior notes and senior secured notes, extending its revolving credit agreement, and amending other financial agreements. These actions aim to extend debt maturities and improve financial flexibility, potentially enhancing the company’s market position and stability.
INNOVATE Corp held its Annual Meeting of Stockholders on June 12, 2025, where key decisions were made regarding the company’s governance and executive compensation. Stockholders elected four directors to the board, approved the compensation of executive officers, decided to hold annual Say on Pay Votes, and ratified the appointment of BDO USA, P.C. as the independent accounting firm for the fiscal year ending December 31, 2025.
On May 23, 2025, INNOVATE Corp. announced that its subsidiary, DBM Global Inc., will distribute a cash dividend of approximately $5.5 million on June 16, 2025. As the largest stockholder, INNOVATE expects to receive $5 million of the payout, highlighting its significant stake in DBM Global and the financial benefits it stands to gain.
On May 20, 2025, DBM Global Inc., a subsidiary of INNOVATE Corp., entered into an amended and restated credit agreement providing $220 million in senior secured debt financing, consisting of an $85 million term loan and a $135 million revolving credit facility. This agreement, led by UMB Bank, aims to repay existing debt and enhance working capital, supporting DBMG’s growth and operational flexibility, with the facility maturing in 2030.
INNOVATE Corp announced its first quarter 2025 results, reporting a consolidated revenue of $274.2 million, a 13% decrease from the previous year, primarily due to declines in its infrastructure segment. Despite the revenue drop, the company achieved significant milestones, including FDA approval for the MediBeacon TGFR system in its life sciences segment and the expansion of its infrastructure backlog to $1.4 billion. The company also anticipates new revenue opportunities in datacasting by year-end, indicating a strategic focus on growth across its operating segments.